jab

British Reporter — A new clinical trial, OCTAVE DUO, investigates if a third vaccine dose for people with weakened immune systems gives a stronger immune response than two doses, UKRI notes. The £2.2 million study is co-funded by UK Research and Innovation (UKRI) and the government’s vaccine taskforce and led by researchers at the University of Glasgow and University of